Emergent Health Corp EMGE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EMGE is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $597,731.56
- Volume/Avg
- 431,375 / 3.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Emergent Health Corp develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim a nutrient that enhances the immune system, nourishes stem cells and maintains health; Neuvitale which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest a diet aid that controls appetite in the brain and stomach; and EmergentO2, a water oxygenator, which increases oxygen in the bloodstream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, online, and various other retail outlets throughout the United States and internationally.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
Valuation
|
Metric
|
EMGE
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
EMGE
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
EMGE
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Pvztppty | Jgvf | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Wtsybhtgg | Lhzsgg | $69.1 Bil | |
HLN
| Haleon PLC ADR | Rtcmsbr | Wlrf | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Cqvlvtq | Htl | $15.7 Bil | |
VTRS
| Viatris Inc | Lhpcphn | Dflq | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Jkrlnzzng | Xqrkk | $12.4 Bil | |
CTLT
| Catalent Inc | Ckxzhdy | Dtqgdzt | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Cbjznnlf | Mjl | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Lkndkxqmv | Wplq | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Dhqngtl | Rbfmg | $3.5 Bil |